Beta Drugs Ltd share price logo

Beta Drugs Ltd

NSE: BETA

BSE: 535022

Small Cap

Pharma Sector

₹1503.30

-19.60

(-1.29%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Beta Drugs Stock Performance

as on June 10, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,490.00
    ₹1,550.00
    downward going graph

    0.88%

    Downside

    3.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹990.10
    ₹2,000.00
    downward going graph

    34.14%

    Downside

    33.04%

    Upside

    downward going graph

Beta Drugs share price movements today

Previous Close
₹1,522.90
Open
₹1,540.00
Volume
9,557.00
Upper Circuit
₹1,827.40
Lower Circuit
₹1,218.40
Day's Low - High
₹1,490.00 - ₹1,550.00
52 Week Low - High
₹990.10 - ₹2,000.00

Beta Drugs Historical Returns

1 Month Return
+ 13.5 %
3 Month Return
+ 35.9 %
1 Year Return
-16.26 %
3 Year Return
+ 101.64 %
5 Year Return
+ 459.21 %

Beta Drugs Fundamentals

as on June 10, 2026 at 4:01 pm IST

Market Cap

₹1,543.75 Cr

Return on Equity (ROE)

15.3

PE Ratio (TTM)

0

Return on capital employed (ROCE)

15.57

Beta (LTM)

0.53

P/B Ratio

14.91

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

0.22

EPS (TTM)

42.02

Book Value

195.25

Beta Drugs Technical Analysis

Track how Beta Drugs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish13
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
4.95
Bullish
CCI (20)
158.63
Bearish
RSI (14)
68.11
Neutral
Momentum (10)
33.4
Bullish
ADI (14)
26.08
Bullish
Ultimate Oscillator (7,14,28)
71.81
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1506.87
Bullish
EMA (20)
1511.39
Bullish
VWMA (20)
1511.25
Bullish
SMA (50)
1509.17
Bullish
EMA (50)
1509.98
Bullish
SMA (200)
1515.9
Bullish
EMA (200)
1514.56
Bullish
KAMA (200)
1508.16
Bullish
DEMA (200)
1512.13
Bullish

Beta Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Beta Drugs Ltd image
Beta Drugs Ltd
NA1,543.7591.84%0.7142362
Wanbury Ltd image
Wanbury Ltd
NA928.5130.33%0.8830599
Bharat Parenterals Ltd image
Bharat Parenterals Ltd
NA0.0047%0.69-44340
Bafna Pharmaceuticals Ltd image
Bafna Pharmaceuticals Ltd
NA412.994.63%0.004145
Aarti Pharmalabs Ltd image
Aarti Pharmalabs Ltd
HOLD5,668.3823.38%0.592722,115
See all

Beta Drugs Stock’s Investor Sentiment and Interest

Search interest for Beta Drugs Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Beta Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
88.29
93.76
100.21
103.39
87.27
93.96
Other Income
0.97
3.96
2.99
2.99
2.31
2.89
Total Income
89.26
97.73
103.19
106.37
89.58
96.86
Expenses
72.18
78.64
80.5
82.08
70.28
76.29
Operating Profit
16.11
15.12
19.71
21.31
16.99
17.67
Operating Profit Margin %
18.25%
16.13%
19.67%
20.61%
19.47%
18.81%
Profit Before Interest, Tax and Depreciation
17.07
19.09
22.69
24.3
19.3
20.57
Interest
1.88
3.29
3.32
3.61
4.43
3.94
Depreciation
3.24
3.57
3.73
4.24
4.39
4.8
Profit Before Tax
11.95
12.23
15.64
16.45
10.48
11.83
Tax Paid
3.01
3.2
3.95
4.23
1.95
2.78
Profit After Tax
8.95
9.03
11.7
12.22
8.52
9.05
Total Net profit including share of profit / Loss from associate company
8.95
9.03
11.7
12.22
8.52
9.05
EPS
9.31
9.4
11.59
12.1
8.4
8.93
Actual EPS
9.31
9.4
11.59
12.1
8.4
8.93
Adjusted EPS
9.31
9.4
11.59
12.1
8.4
8.93
Diluted EPS
9.31
9.4
-
12.1
8.4
8.93

Beta Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
65.93
90.81
116.12
183.84
227.11
295.71
362.36
384.83
Other Income
0.37
0.41
0.5
0.76
0.75
1.36
6.44
11.18
Total Income
66.3
91.22
116.62
184.59
227.87
297.07
368.79
396.01
Expenses
54.12
72.9
91.38
141.14
173.99
235.72
292.32
309.15
Operating Profit
11.81
17.91
24.74
42.7
53.12
59.99
70.04
75.68
Operating Profit Margin %
17.91%
19.72%
21.31%
23.23%
23.39%
20.29%
19.33%
19.67%
Profit Before Interest, Tax and Depreciation
12.18
18.32
25.24
43.45
53.88
61.36
76.47
86.86
Interest
1.43
2.59
2.42
1.9
2.41
2.82
6.99
15.31
Depreciation
2.84
3.76
6.87
7.25
10.41
9.78
12.51
17.15
Profit Before Tax
7.91
11.97
15.95
34.3
41.06
48.76
56.97
54.4
Tax Paid
-0.13
2.56
4.23
9.48
10.34
12.32
14.55
12.91
Profit After Tax
8.04
9.42
11.72
24.83
30.72
36.44
42.42
41.48
Total Net profit including share of profit / Loss from associate company
8.04
9.42
11.72
24.83
30.72
36.44
42.42
41.48
EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
40.92
Actual EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
40.92
Adjusted EPS
8.86
9.46
11.62
24.59
30.43
36.1
42.02
40.92
Diluted EPS
9.3
9.93
12.2
25.82
31.95
37.9
42.02
40.92

Beta Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.1
0.11
8.41
18.6
29.63
23.38
30.93
36.14
Cash Flow from Investing Activities
-10.79
-20.78
-15.06
-5.86
-21.76
-19.07
-13.98
-35.72
Cash Flow from Financing Activities
5.45
12.07
8.72
-7.72
-0.98
-2.47
-7.49
117.97
Net Cash Flow
11.76
-8.61
2.09
5.04
6.9
1.84
9.47
118.39

Beta Drugs Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Nov 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Nov 2025
Dec 2025
Mar 2026
Promoters
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
66.73%
64.9%
66.73%
DII
0%
0.02%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.9%
0.29%
FII
0%
0.32%
0%
0%
0%
0%
0%
0%
0%
0%
0%
1.14%
0.9%
Public
32.93%
32.92%
32.88%
32.25%
31.95%
31.94%
31.95%
32.2%
32.11%
32.07%
32.08%
32.07%
32.07%
Total Outstanding Shares
96,13,790
96,13,790
96,13,790
96,13,790
96,13,790
96,13,860
96,13,860
1,00,94,553
1,00,94,553
1,00,94,553
1,00,94,553
1,00,94,553
1,00,94,553
Total Shareholders
1,722
1,928
2,116
2,323
2,567
2,793
2,882
3,054
3,139
3,184
3,003
3,694
3,184

Beta Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Beta Drugs.

  • Beta Drugs Ltd Earnings Results

    Beta Drugs Ltd’s net profit jumped 0.22% since last year same period to ₹9.05Cr in the Q4 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated 6.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, BETA stock has moved up by 13.5%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 64.90% to 66.73% in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 147.6% return, outperforming this stock by 46.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 38.9% return, outperforming this stock by 55.1%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 32.07% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.14% to 0.91% in Mar 2026 quarter

About Beta Drugs Ltd

Beta Drugs Limited is a part of the Adley Group, established in 1985 by its promoter Vijay Batra. It is a pharmaceutical formulation manufacturing company that produces and markets drugs to domestic and international customers. The Company specializes in the production of oncology products such as anticancer tablets, capsules, injections and lyophilized injections. With a portfolio of over 50 products catering to various oncology diseases such as breast cancer, brain cancer, bone cancer, lung cancer, mouth cancer, head and neck cancer, prostate cancer, haematology and cervics oeaophagus, Beta Drugs is an important contributor to the healthcare industry. The Company was originally incorporated in Himachal Pradesh in 2005 as a private limited company and was converted into a public limited company in 2017. Under the charge of Vijay Batra, Beta Drugs has become a well-recognized and trusted international healthcare brand.

Revenue: ₹93.96Cr as on March 2026 (Q4 FY26)
Net Profit: ₹9.05Cr as on March 2026 (Q4 FY26)
Listing date: 12 Oct, 2017
Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
IndustryPharmaceuticals
CEORahul Batra
E-voting on sharesClick here to vote

FAQs

What is Beta Drugs share price today?

Beta Drugs share price today stands at ₹1503.3 as on at the close of the market. Beta Drugs share today touched a day high of ₹1550 and a low of ₹1490.

What is the 52 week high and 52 week low range for Beta Drugs share?

Beta Drugs touched a 52 week high of ₹2000 and a 52 week low of ₹990.1. Beta Drugs share price today i.e. is closed at ₹1503.3, which is -24.84% down from its 52 week high and 51.83% up from its 52 week low.

What is Beta Drugs's market capitalisation today?

Beta Drugs market capitalisation is ₹1,543.75 Cr as on .

How to buy Beta Drugs shares?

To buy Beta Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BETA or Beta Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Beta Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Beta Drugs trading volume today?

Beta Drugs trading volume is 9,557.00 as on . This means that 9,557.00 shares of Beta Drugs were bought and sold on the stock market during today's trading session.